President & CEO of CELLDEX THERAPEUTICS, INC (CLDX, Financial) Anthony S Marucci buys 12,000 shares of CLDX on 09/10/2010 at an average price of $3.45 a share.
Celldex Therapeutics, Inc has a market cap of $111.29 million; its shares were traded at around $3.49 with and P/S ratio of 7.33.
CLDX is in the portfolios of Paul Tudor Jones of The Tudor Group.
Celldex Therapeutics, Inc has a market cap of $111.29 million; its shares were traded at around $3.49 with and P/S ratio of 7.33.
CLDX is in the portfolios of Paul Tudor Jones of The Tudor Group.
CFO Recent Trades:
- Buy: Sr. VP & CFO Avery W Catlin bought 2,000 shares of CLDX stock on 09/08/2010 at the average price of 3.51. Avery W Catlin owns at least 2,000 shares after this. The price of the stock has decreased by 0.57% since.
Directors and Officers Recent Trades:
- Buy: Director Timothy M Shannon bought 5,000 shares of CLDX stock on 09/10/2010 at the average price of 3.41. Timothy M Shannon owns at least 100 shares after this. The price of the stock has increased by 2.35% since.
- Buy: Director Harry Jr Penner bought 3,000 shares of CLDX stock on 09/09/2010 at the average price of 3.49. Harry Jr Penner owns at least 3,000 shares after this. The price of the stock has decreased by 0% since.
- Buy: Director Charles R Schaller bought 5,000 shares of CLDX stock on 09/09/2010 at the average price of 3.45. Charles R Schaller owns at least 5,000 shares after this. The price of the stock has increased by 1.16% since.
